- Q1 2024 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptApr 23, 2024$17.68 (+3.42%)Earnings
- Q4 2023 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptFeb 28, 2024$20.36 (-2.54%)Earnings
- Kiniksa Pharmaceuticals Ltd at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q3 2023 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptOct 31, 2023$15.25 (-2.74%)Earnings
- Q2 2023 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptJul 25, 2023$19.48 (+30.39%)Earnings
- Kiniksa Pharmaceuticals Ltd at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Q1 2023 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptMay 02, 2023$12.59 (+14.66%)Earnings
- Q4 2022 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptFeb 28, 2023$12.86 (-3.45%)Earnings
- Kiniksa Pharmaceuticals Ltd at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Kiniksa Pharmaceuticals Ltd at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Q3 2022 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptNov 01, 2022$12.8 (+12.08%)Earnings
- Q2 2022 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptAug 03, 2022$10.68 (+7.12%)Earnings
- Q1 2022 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptMay 03, 2022$10.11 (+7.44%)Earnings
- Q4 2021 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptFeb 22, 2022$10.62 (-0.93%)Earnings
- Kiniksa Pharmaceuticals Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Q3 2021 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptNov 01, 2021$12.73 (+22.52%)Earnings
- Q2 2021 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptAug 03, 2021$13.69 (-15.65%)Earnings
- Kiniksa Pharmaceuticals Ltd at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Kiniksa Pharmaceuticals Ltd FDA Approval of ARCALYST (rilonacept) for Recurrent Pericarditis Conference Call TranscriptMar 18, 2021
- Kiniksa Pharmaceuticals Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Kiniksa Pharmaceuticals Ltd Rilonacept Analyst Day TranscriptSep 29, 2020
- Kiniksa Pharmaceuticals Ltd at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Kiniksa Pharmaceuticals Ltd Annual Shareholders Meeting TranscriptJun 30, 2020
- Kiniksa Pharmaceuticals, Ltd. - Special Call TranscriptJun 29, 2020
- Kiniksa Pharmaceuticals Ltd at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- Kiniksa Pharmaceuticals Ltd at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Kiniksa Pharmaceuticals Ltd at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Kiniksa Pharmaceuticals Ltd at Barclays Global Healthcare Conference TranscriptMar 12, 2019
Q4 2022 Kiniksa Pharmaceuticals Ltd Earnings Call Transcript
Good day, and thank you for standing by, and welcome to the Kiniksa Pharmaceuticals Fourth Quarter and Full Year 2022 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Rachel Frank, Head of Investor Relations. Please go ahead.
Thank you, operator. Good morning, everyone, and thank you for joining Kiniksa's call to discuss our fourth quarter and full year 2022 financial results and recent portfolio execution. A press release highlighting these results can be found on our website under the Investors & Media section. As for the agenda, our Chief Executive Officer, Sanj K. Patel, will start with an introduction. Ross Moat, our Chief Commercial Officer, will provide an update on our ARCALYST commercial execution. Then Mark Ragosa, our Chief Financial Officer, will review our fourth quarter and full year 2022 financial results. And finally, Sanj will return for
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)